US Stem Cell Inc (USRM)

[docprep]

I really don't get how the PPS is not up to .15+

USRM is days or weeks from RMAT approval which will soar revenues in US

Now even advertising Myocell.


Even notwithstanding, revenues have consistently and substantially increased over the last year, and all toxic convertible debt has been paid off.


Not to mention the obvious elephant in the room...stem cell medicine and therapies (i.e regenerative medicine) are the future of medicine and USRM has products and therapies (Myocell, Vetbiologics, etc.) on the upper, if not the top, of the field.


The PPS has.....yes look at the chart....substantially increased, in a reasonably argued stair step pattern of late, with gradual higher highs and higher lows, with the small exception of the drop in the last 2-3 trading sessions.

This drop can clearly be contributed solely to market manipulation, low volume, and the CEO vague blog as to RMAT approval date.



The low volume on no-news days is contributed to most shares being consolidated and held by longs.

The RMAT approval date was presumed by many in here and posted about so many times, that it reached a consensus that was not based in reality or substantiated in evidence.

The CEO blog, as vague as it is as far as dates, clearly states that the ball is now in the FDA hands, acknowledging the receipt of the supplemental requested material.

Thus means RMAT approval, which little can deny was tailor made for USRM, is on track, and will likely be approved anyday.


ANY nonsense about .06,s and .07s is just that IMHO nonsense. Furthermore the nonsense that RMAT approval is reflective in the PPS already is nonsense based on any reasonable calculation of the value of the company. At its current revenue/debt, and taking into its potential, there can be little doubt that the PPS of .10-.15 is right where it belongs. Anything less than that is bargain basement.


When RMAT is approved, the revenue streams are easily and immediately increased 10-30 fold, and as the company expands, could and will exponentially increase unless the more likely buyout occurs.


USRM, long and strong.